Your Search Results

The aortic regurgitation problem: an imaging and practical perspective

02 Feb 2024 – From PCR Imaging Valves Madrid 2024

In this session, discover strategies to address biases in aortic regurgitation, influenced by factors like etiology, natural history, surgical risk, age, and gender, and explore an imaging-centric approach to better quantify aortic regurgitation and comprehend its relationship with left ventricular remodeling and outcomes. Anticipate forthcoming guidelines...

The aortic regurgitation problem: an imaging and practical perspective

TAVI essentials: anatomical factors, prosthesis selection, and complication management

02 Feb 2024 – From PCR Imaging Valves Madrid 2024

Discover a comprehensive exploration of critical considerations in TAVI in this section. From anatomical factors guiding the choice between TAVI and SAVR to strategies for selecting the optimal TAVI prosthesis for individual patients, each topic offers essential insights. Gain valuable insights into navigating TAVI for bicuspid...

TAVI essentials: anatomical factors, prosthesis selection, and complication management

Comprehensive assessment of mitral valve disorders and treatment outcomes

02 Feb 2024 – From PCR Imaging Valves Madrid 2024

This session offers a comprehensive exploration of mitral valve disorders, covering diagnosis and severity assessment from multiple perspectives. From morphology-based diagnosis to echocardiography and CMR assessments, gain insights into distinguishing between rheumatic and calcific mitral stenosis, evaluating outcomes post-TMVR and surgical repair, and assessing bioprosthetic and...

Comprehensive assessment of mitral valve disorders and treatment outcomes

Optimizing case selection and procedure guidance in transcatheter mitral valve interventions

02 Feb 2024 – From PCR Imaging Valves Madrid 2024

This session examines the critical aspect of case selection for various transcatheter mitral valve interventions, ranging from TEER in secondary mitral regurgitation to balloon valvotomy in mitral stenosis and transcatheter mitral valve replacement. It explores the intricacies of procedure planning and guidance for TEER, alongside methods...

Optimizing case selection and procedure guidance in transcatheter mitral valve interventions

Tricuspid valve disease: diagnosis and classification

03 Feb 2024 – From PCR Imaging Valves Madrid 2024

Discover, in this comprehensive 3rd episode of PCR Imaging Valves Madrid 2024, the nuances of diagnosing and grading tricuspid valve disease, including insights into normal and abnormal function post-repair or replacement, the pivotal role of imaging in valve quantification and device selection, strategies for assessing right ventricular...

Tricuspid valve disease: diagnosis and classification

Advanced imaging strategies in transcatheter tricuspid valve therapies

03 Feb 2024 – From PCR Imaging Valves Madrid 2024

In this PCR Imaging Valves Madrid 2024 session, discover the use of various imaging techniques in transcatheter tricuspid valve therapies, ranging from standard TEE screening to comprehensive intra-procedural assessments, facilitating optimal device selection, procedural success, and post-procedural monitoring.

Advanced imaging strategies in transcatheter tricuspid valve therapies

Multivalvular disease: diagnostic challenges and treatment strategies for aortic and mitral valve disorders

03 Feb 2024 – From PCR Imaging Valves Madrid 2024

Addressing the complex diagnostic challenges in aortic stenosis and regurgitation, this session examines the timing of treatment initiation and the decision-making process when aortic valve disease coincides with aortic pathology. It also explores the ongoing healthcare burden posed by mitral regurgitation and stenosis, emphasizing the importance...

Multivalvular disease: diagnostic challenges and treatment strategies for aortic and mitral valve disorders

Multivalvular disease: mitral and aortic valve challenges explored

03 Feb 2024 – From PCR Imaging Valves Madrid 2024

Explore cutting-edge transcatheter valve interventions for mitral and aortic valve disorders, including valve-in-valve procedures and management strategies for paravalvular leakages, and learn about diagnosing and treating mitral annular calcification and transcatheter options in infective endocarditis.

Multivalvular disease: mitral and aortic valve challenges explored

TAVI for patients with concomitant coronary artery disease - LIVE case

17 Feb 2024 – From PCR Tokyo Valves 2024

An 88-year-old male presented a severe symptomatic aortic valve with preserved LV function (64%), a coronary artery disease with a LAD PCI a few years ago and a significant (75%) RCA stenosis with an FFR angio at 0.74. He also has a short membrane septum (2.5...

TAVI for patients with concomitant coronary artery disease - LIVE case

PCR Tokyo Valves 2024 Welcome Ceremony

17 Feb 2024 – From PCR Tokyo Valves 2024

After a brief overview of the Course's history and the success of the PCR Family's various Courses, join the Course Directors as they unveil the new venue for the 2024 edition, introduce the team, and reveal the schedule for three intense days featuring a diverse and...

Challenges in TEER for secondary mitral regurgitation

17 Feb 2024 – From PCR Tokyo Valves 2024

Explore this session on secondary mitral regurgitation to understand the ideal case predictors gleaned from trials like EVEREST, COAPT, or MITRA-FR, delve into patient selection conundrums, including optimal medical therapy, examine technical challenges posed by atrial functional mitral regurgitation, and gain insights into TEER techniques for...

Challenges in TEER for secondary mitral regurgitation

The optimal first valve choice for patients with aortic stenosis - Key considerations for lifetime management

17 Feb 2024 – From PCR Tokyo Valves 2024

This session tackles the pressing topic of TAVI's success in treating aortic stenosis, particularly in younger patients, and the ensuing questions regarding device durability, potential follow-up procedures, and the interplay between TAVI and surgical options. The aim is to ensure optimal decision-making that prioritizes patient welfare...

Achieving the optimal outcome using the latest self-expandable TAVI - LIVE case

17 Feb 2024 – From PCR Tokyo Valves 2024

An 86-year-old woman presented severe symptomatic aortic stenosis and coronary artery disease with a preserved LV function. The operators performed a PCI of the RCA ostium one month ago. The CT showed a small femoral access (diameter: 5.3 to 4.9 mm).
After a predilatation with a 20 mm...

Achieving the optimal outcome using the latest self-expandable TAVI - LIVE case

Contemporary techniques for TAV-in-SAV interventions

18 Feb 2024 – From PCR Tokyo Valves 2024

Thanks to this session, take a look at the current outcomes of TAV-in-SAV, analyse the different types of valves and their fracturability, find out more, through case studies, about two different TAV-in-SAV techniques, with or without a stent, and learn how to avoid patient prosthesis mismatch...